UK markets open in 2 hours 35 minutes
NIKKEI 225
38,193.78 +119.80 (+0.31%) HANG SENG
18,859.60 +321.79 (+1.74%) CRUDE OIL
79.78 +0.52 (+0.66%) GOLD FUTURES
2,358.90 +18.60 (+0.79%) DOW
39,387.76 +331.36 (+0.85%) Bitcoin GBP
50,267.76 +1,064.71 (+2.16%)
Aspen Pharmacare Holdings Limited (LDZA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:15AM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 5.10B |
| Enterprise value | 6.33B |
| Trailing P/E | 20.54 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.34 |
| Price/book (mrq) | 1.17 |
| Enterprise value/revenue | 0.15 |
| Enterprise value/EBITDA | 0.79 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.75 |
| 52-week change 3 | 42.14% |
| S&P500 52-week change 3 | 26.43% |
| 52-week high 3 | 11.60 |
| 52-week low 3 | 7.70 |
| 50-day moving average 3 | 10.31 |
| 200-day moving average 3 | 9.24 |
Share statistics
| Avg vol (3-month) 3 | 10 |
| Avg vol (10-day) 3 | 33 |
| Shares outstanding 5 | 444.24M |
| Implied shares outstanding 6 | 451.38M |
| Float 8 | 278.49M |
| % held by insiders 1 | 19.33% |
| % held by institutions 1 | 63.01% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.17 |
| Forward annual dividend yield 4 | 1.52% |
| Trailing annual dividend rate 3 | 3.42 |
| Trailing annual dividend yield 3 | 30.27% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 31.21% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 20 Sept 2023 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in ZAR.Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 11.40% |
| Operating margin (ttm) | 16.56% |
Management effectiveness
| Return on assets (ttm) | 4.10% |
| Return on equity (ttm) | 6.05% |
Income statement
| Revenue (ttm) | 42.7B |
| Revenue per share (ttm) | 96.12 |
| Quarterly revenue growth (yoy) | 10.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 9.88B |
| Net income avi to common (ttm) | 4.87B |
| Diluted EPS (ttm) | 0.55 |
| Quarterly earnings growth (yoy) | -13.50% |
Balance sheet
| Total cash (mrq) | 11.6B |
| Total cash per share (mrq) | 26.1 |
| Total debt (mrq) | 36.12B |
| Total debt/equity (mrq) | 42.19% |
| Current ratio (mrq) | 1.92 |
| Book value per share (mrq) | 192.66 |
Cash flow statement
| Operating cash flow (ttm) | 6.27B |
| Levered free cash flow (ttm) | 22.38M |
© 2024 Yahoo. All rights reserved.